Real-world data of HER2-low metastatic breast cancer: A population based cohort study

BACKGROUND: With the introduction of investigational human epidermal growth factor receptor 2 (HER2) targeting treatments, thorough understanding of breast cancer with different HER2 expression levels is critical. The aim of this study was to compare clinicopathologic characteristics and survival of...

Descripción completa

Detalles Bibliográficos
Autores principales: Holthuis, Emily I., Vondeling, Gerard T., Kuiper, Josephina G., Dezentjé, Vincent, Rosenlund, Mats, Overbeek, Jetty A., van Deurzen, Carolien H.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663525/
https://www.ncbi.nlm.nih.gov/pubmed/36375389
http://dx.doi.org/10.1016/j.breast.2022.11.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663525/
https://www.ncbi.nlm.nih.gov/pubmed/36375389
http://dx.doi.org/10.1016/j.breast.2022.11.003

Ejemplares similares